SEC Form 4Coverage since Jul 27, 2026
$NXTC insider trading
Over the last 12 months, NextCure insiders reported 2 buys totaling $1.7M and no sales across SEC Form 4 filings.
- Bought · 12m
- $1.7M 2 events
- Sold · 12m
- — 0 events
- Events · 12m
- 2 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $NXTC · 12Mvia TradingView
Top insiders · 12m
ADAR1 Capital Management, LLC—2× · $1.7M
All insider trades
2 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | ADAR1 Capital Management, LLC10% | ▲ Buy | 329,153 | $4.93 | $1.6M | +83.7% | 9 tranches · indirect |
| Jul 29, 2026 | ADAR1 Capital Management, LLC10% | ▲ Buy | 17,608 | $4.98 | $88K | +4.7% | 4 tranches · indirect |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $NXTC feed.